DIH makes robotic rehabilitation devices used in physical therapy settings — hospitals, outpatient clinics, and research centers — to help patients recover motor function after strokes, spinal cord injuries, and other neurological conditions. DIH's core product is the Lokomat, a robotic exoskeleton that guides patients through walking motion on a treadmill to rewire neural pathways. The broader product lineup covers a full continuum of rehabilitation: the lower extremity segment includes the Erigo (ICU-level early mobilization), Andago (overground walking assist), and C-Mill (balance and gait treadmill); the upper extremity Armeo line offers robotic arm therapy across patient severity levels. DIH also distributes CAREN and GRAIL research-grade motion analysis platforms to universities and military labs under an exclusive distribution agreement with Motek, a related but unconsolidated entity. DIH's primary revenue driver is direct hardware sales — each device is a large capital purchase for the customer — supplemented by clinical training, technical service, and software subscriptions. Products are manufactured in Switzerland and the Netherlands, and sold directly in key markets like the U.S. and Germany, and through indirect channels elsewhere. DIH's growth strategy focuses on deepening penetration in U.S. and European hospitals (currently around 25% of its target hospital universe, with an internal goal of 66%), expanding into the outpatient market through modularized products, and acquiring smaller regional rehabilitation device companies to consolidate onto its global commercial platform.